Abbott实验室打破了对收入的预期,提升了2025年的指导,并宣布了红利。 Abbott Labs beat earnings expectations, raised 2025 guidance, and declared a dividend.

Abbott实验室报告说,第二季度收入强劲,达到了1.26 EPS和11.14亿美元收入的预期水平,比上一年增长7.4%。 Abbott Laboratories reported strong second-quarter earnings, meeting expectations with $1.26 EPS and $11.14 billion in revenue, a 7.4% year-over-year increase. 该公司将其2025年全年收入指导提高到每股5.10-5.20美元,预计Q3收入为1.28-1.32美元。 The company raised its full-year 2025 earnings guidance to $5.10–$5.20 per share and projected Q3 earnings of $1.28–$1.32. 它宣布季度股息为每股0.59美元,收益1.8%,付款日期为11月17日。 It declared a quarterly dividend of $0.59 per share, yielding 1.8%, with a payment date of November 17. 机构投资者持有75.18%的股份,股票具有协商一致的“机动购买”评级,目标价格为146.17美元。 Institutional investors hold 75.18% of shares, and the stock has a consensus "Moderate Buy" rating with a target price of $146.17.